- Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Karp, J.E., Merz, W.G., Hendricksen, C., Laughon, B., Redden, T., Bamberger, B.J., Bartlett, J.G., Saral, R., Burke, P.J. Ann. Intern. Med. (1987)









